Stability and stabilization studies of TAK-599 (ceftaroline fosamil), a novel N-phosphono type prodrug of anti-methicillin resistant Staphylococcus aureus cephalosporin T-91825

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 10, 2008, Pages 1406-1411

  Ikeda, Yukihiro ^a   Ban, Junko ^a   Ishikawa, Tomoyasu ^a   Hashiguchi, Shohei ^a   Urayama, Shinichi ^a   Horibe, Hidetoshi ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Ceftaroline fosamil; Crystallinity; Kinetic analysis; Stability; Stabilization; TAK 599

Indexed keywords

ACETIC ACID; CEFTAROLINE FOSAMIL; CEPHALOSPORIN DERIVATIVE; PHOSPHONIUM DERIVATIVE; PRODRUG; T 91825; TAK 599; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CORRELATION ANALYSIS; CRYSTAL; CRYSTALLIZATION; DRUG FORMULATION; DRUG QUALITY; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; FREEZE DRYING; KINETICS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOISTURE; PHYSICAL CHEMISTRY; SOLID STATE; TEMPERATURE DEPENDENCE;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FREEZE DRYING; METHICILLIN RESISTANCE; PRODRUGS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; STAPHYLOCOCCUS AUREUS; WATER; X-RAY DIFFRACTION;

EID: 54349094745     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.1406     Document Type: Article

References (29)

1. Yamaguchi T., Nishimura M., Okamoto R., Takeuchi T., Yamamoto K., Int. J. Pharm., 85, 87-96 (1992).
2. Yamaguchi T., Nishimura M., Okamoto R., Takeuchi T., Yamamoto K., Chem. Pharm. Bull., 41, 1812-1816 (1993).
3. Ueno Y., Yonemochi E., Tozuka Y., Yamamura S., Oguchi T., Yamamoto K., J. Pharm. Pharmacol., 50, 1213-1220 (1998).
4. Wu L. S., Gerard C., Koval C., Rowe S., Hussain M. A., J. Pharm. Biomed. Anal., 12, 1043-1046 (1994).
5. Pikal M. J., Lukes A. L., Lang J. E., Gaines K., J. Pharm. Sci., 67, 767-773 (1978).
6. Kaneniwa N., Otsuka M., Chem. Pharm. Bull., 33, 1660-1668 (1985).
7. Kitamura S., Koda S., Miyamae A., Yasuda T., Morimoto Y., Int. J. Pharm., 59, 217-224 (1990).
8. Mimura H., Gato K., Kitamura S., Kitagawa T., Kohda S., Chem. Pharm. Bull., 50, 766-770 (2002).
9. Terada K., Kitano H., Yoshihashi Y., Yonemochi E., Pharm. Res., 17, 920-924 (2000).
10. Yoshihashi Y., Kitano H., Yonemochi E., Terada K., Int. J. Pharm., 204, 1-6 (2000).
11. Terada K., Yoshihashi Y., Netsusokutei, 25, 105-110 (1998).
12. Kawakami K., Numa T., Ida Y., J. Pharm. Sci., 91, 417-423 (2002).
13. Ashizawa K., Uchikawa K., Hattori S., Ishibashi Y., Miyake Y., Sato T., Yakugaku Zasshi, 110, 191-201 (1990).
14. Kamiya K., Takamoto M., Wada Y., Nishikawa M., Chem. Pharm. Bull., 29, 608-615 (1981).
15. Jacobs G. P., Wills P. A., Radiat. Phys. Chem., 31, 685-691 (1988).
16. Kitamura S., Miyamae A., Koda S., Morimoto Y., Int. J. Pharm., 56, 125-134 (1989).
17. Otsuka M., Kaneniwa N., Int. J. Pharm., 62, 65-73 (1990).
18. Mimura H., Kitamura S., Okamoto Y., Yasuda T., Drug Stability, 1, 34-39 (1995).
19. Ishikawa T., Matsunaga N., Tawada H., Kuroda N., Nakayama Y., Ishibashi Y., Tomimoto M., Ikeda Y., Tagawa Y., Iizawa Y., Okonogi K., Hashiguchi S., Miyake A., Bioorg. Med. Chem., 11, 2427 (2003).
20. Iizawa Y., Nagai J., Ishikawa T., Hashiguchi S., Nakao M., Miyake A. Okonogi K., J. Infect. Chemother., 10, 146-156 (2004).
21. Hermans H. P., Weidinger A. W., J. Appl. Phys., 19, 49 (1948).
22. Prout G., Parenter J., Sci. Technol., 36, 199-204 (1982).
23. Jander W., Z. Anorg. Allg. Chem., 163, 1-30 (1927).
24. Avrami M., J. Chem. Phys., 7, 1103-1112 (1939).
25. Manpel K. L., Z. Phys. Chem., A187, 235-249 (1940).
26. Okusa N., Chem. Pharm. Bull., 23, 794-802 (1975).
27. Seki H., Hayashi T., Okusa N., Yakuzaigaku, 40, 201-207 (1980).
28. Takahashi Y., Nakashima K., Nakagawa H., Sugimoto I., Chem. Pharm. Bull., 32, 4963-4970 (1984).
29. Authelin J., Int. J. Pharm., 303, 27-53 (2005).